A detailed history of Price T Rowe Associates Inc transactions in Accolade, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 19,540 shares of ACCD stock, worth $73,079. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,540
Previous 16,954 15.25%
Holding current value
$73,079
Previous $204,000 0.49%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$9.22 - $15.02 $23,842 - $38,841
2,586 Added 15.25%
19,540 $205,000
Q4 2023

Feb 14, 2024

SELL
$6.5 - $12.85 $81,445 - $161,010
-12,530 Reduced 42.5%
16,954 $204,000
Q3 2023

Nov 14, 2023

BUY
$10.45 - $15.02 $16,166 - $23,235
1,547 Added 5.54%
29,484 $312,000
Q2 2023

Aug 14, 2023

BUY
$10.52 - $16.06 $13,728 - $20,958
1,305 Added 4.9%
27,937 $377,000
Q1 2023

May 15, 2023

BUY
$7.32 - $14.38 $5,431 - $10,669
742 Added 2.87%
26,632 $383,000
Q4 2022

Feb 14, 2023

BUY
$7.19 - $13.16 $25,380 - $46,454
3,530 Added 15.79%
25,890 $202,000
Q3 2022

Nov 14, 2022

BUY
$0.0 - $12.8 $0 - $59,993
4,687 Added 26.52%
22,360 $256,000
Q2 2022

Aug 15, 2022

SELL
$5.28 - $18.9 $4.14 Million - $14.8 Million
-784,783 Reduced 97.8%
17,673 $131,000
Q1 2022

May 16, 2022

BUY
$12.92 - $27.18 $35,607 - $74,908
2,756 Added 0.34%
802,456 $14.1 Million
Q4 2021

Feb 14, 2022

SELL
$21.96 - $42.69 $11.6 Million - $22.6 Million
-528,423 Reduced 39.79%
799,700 $21.1 Million
Q3 2021

Nov 15, 2021

SELL
$41.3 - $54.56 $2.85 Million - $3.77 Million
-69,100 Reduced 4.95%
1,328,123 $56 Million
Q2 2021

Aug 16, 2021

BUY
$38.61 - $55.0 $21.5 Million - $30.7 Million
557,549 Added 66.4%
1,397,223 $75.9 Million
Q1 2021

May 17, 2021

BUY
$38.1 - $59.09 $2.55 Million - $3.96 Million
66,945 Added 8.66%
839,674 $38.1 Million
Q4 2020

Feb 16, 2021

BUY
$33.26 - $59.72 $25.7 Million - $46.1 Million
772,729 New
772,729 $33.6 Million

Others Institutions Holding ACCD

About Accolade, Inc.


  • Ticker ACCD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 71,938,896
  • Market Cap $269M
  • Description
  • Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...
More about ACCD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.